Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.
about
Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?The microbiome in asthmaBiomarkers in the Management of Difficult AsthmaAltered Innate Immune Responses in Neutrophils from Patients with Well- and Suboptimally Controlled AsthmaThe respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitroPathogenic CD4+ T cells in patients with asthma.Microbiota in T-cell homeostasis and inflammatory diseasesMicrobiome diversity and asthma and allergy risk.The respiratory microbiome and innate immunity in asthmaThe changing face of asthma and its relation with microbesA comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).The Microbiome and the Respiratory TractObesity, Asthma, and the Microbiome.Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanismsAirway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes.Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistanceHigh IFN-γ and low SLPI mark severe asthma in mice and humans.The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patientsLung Microbiome Analysis in Steroid-Naїve Asthma Patients by Using Whole SputumAirway Surfactant Protein D Deficiency in Adults With Severe AsthmaThe Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.Neutrophilic Inflammation in Asthma and Association with Disease Severity.Advanced Role of Neutrophils in Common Respiratory DiseasesThe microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.Novel approaches to the management of noneosinophilic asthma.Diagnosis and investigation in the severe asthma clinic.IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceAirway Microbiota and the Implications of Dysbiosis in Asthma.Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Nothing New Under the Sun.The microbiome in asthma.Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Phenotype-Driven Therapeutics in Severe Asthma.Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma.Eosinophilic and Non-Eosinophilic Asthma.Airway and serum biochemical correlates of refractory neutrophilic asthma.Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations.Decreased FEV1 % in asthmatic adults in Scottish homes with high Environmental Relative Moldiness Index values.Allergen specific immunotherapy enhanced defense against bacteria via TGF-β1-induced CYP27B1 in asthma.
P2860
Q26768646-BAFBC5AB-D87C-47C5-B9DC-9092380D0D5EQ28080434-AC1A9620-FFBD-49A0-A244-7ED6CAE28610Q28081109-C1836D4D-6B6C-41D8-8C97-C568D03CC7DEQ28395377-B1C7A31C-00DB-4139-83B2-6F0559974115Q28396321-12E7F209-322D-4173-AAD7-294557A40194Q28596831-7D637636-593F-4D40-A78E-7D3919B90534Q30252507-4515A42A-2E57-4237-A9B1-279CAADCFAB7Q33754038-D09A73BF-9729-45F6-9165-2F27040CEBA1Q35230090-0759E88F-6B83-47EE-91AF-3EEB9388DEADQ35430866-DAB35694-1DA5-4188-9084-678D7BA31BD2Q35594963-B9A6307F-FC3D-4FCB-8CD2-B5A490216C02Q35824636-40046092-BE57-4171-BF14-C2E4B9DF4F3BQ35829947-A7F2705F-409F-4363-8C3F-90AC5C4C76B3Q35926923-5BB9A5FD-3809-4A49-AC00-B20C23F205C6Q35947771-CB5F2D35-71DB-42BC-8124-DBF1C83B73DAQ35989768-0B357BBC-0276-48D6-8786-31616950E4F0Q36000796-6A17DD3C-BF01-4E8B-8BFE-8EDCCB882FC7Q36040504-4321BF7D-2136-4508-BF1C-E8F6D4E5BACFQ36254351-4054B00B-77F7-4336-9464-54B5A2F63A6EQ37092477-07513EFC-0C1E-4848-A70D-8C157285849FQ37094632-A69DA447-A6C9-4E0A-A388-708FF0AF6B30Q37643936-D3269FE7-280B-41AD-A1FB-01BDCB880DDBQ38622649-421C138D-C2D3-4D99-B971-6D65F798D294Q38645834-092EC273-E257-4788-8C0D-72FDF7B2A99FQ38739370-D311880E-A4E2-46DD-AE71-F70C410BD553Q38750982-9178F6CE-B960-4905-895A-2231170E88D1Q38756064-C30FBDAD-B853-4687-989E-08B433D022F6Q38770013-B42D9B4A-3862-4F6A-BEF1-0CE3726EAA77Q38780046-18C5C734-09A9-4DFB-A729-3463CF65284BQ38890722-5FD72B9C-50E8-484B-BB58-9878A75F2C5DQ38892965-614F33F3-234D-4619-B12C-96592A866238Q38949256-571FA99F-5016-43F6-87F8-E1F0943305B6Q39063083-1D2FB4C1-045C-496F-94BB-D8A96828B441Q39148802-D431519D-8158-4D3A-9FBB-A5AE45337E37Q39402899-D4D28726-26A0-4958-8BC9-7F7FF7A06D47Q40046428-3C5A422D-1B3A-479C-9E04-CBB0369387F3Q40344650-E4266B13-0AA1-485C-B0EE-BEB5BD5AFD72Q40423635-A2DCB5BF-B889-4894-9B79-0F7DA4B6756CQ41549678-7E34A72A-FEEB-4BB2-AEF7-2D723B912243Q41991209-3A7BC222-233F-403B-87E4-0F9D8E130501
P2860
Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potentially pathogenic airway ...... tment resistant severe asthma.
@ast
Potentially pathogenic airway ...... tment resistant severe asthma.
@en
type
label
Potentially pathogenic airway ...... tment resistant severe asthma.
@ast
Potentially pathogenic airway ...... tment resistant severe asthma.
@en
prefLabel
Potentially pathogenic airway ...... tment resistant severe asthma.
@ast
Potentially pathogenic airway ...... tment resistant severe asthma.
@en
P2093
P2860
P1433
P1476
Potentially pathogenic airway ...... tment resistant severe asthma.
@en
P2093
Benjamin J Green
Kenneth D Bruce
Laurie Lau
Mary P Carroll
Peter H Howarth
Surasa Wiriyachaiporn
Valia Kehagia
P2860
P304
P356
10.1371/JOURNAL.PONE.0100645
P407
P577
2014-06-23T00:00:00Z